PTCT
NASDAQ
US
PTC Therapeutics, Inc. - Common Stock
$67,77
▼ $-0,98
(-1,43%)
Vol. 483K
9
Punteggio di Qualità
ok
Analisi approfondita
1/5
fail
Ricavi ✓
Utile netto ✗
>IPO ✗
Cap. mercato
$6.1B
P/E
8,1
ROE
-351,9%
Margine
42,3%
D/E
84892,86
Beta
0,47
52W
$36–$88
Consenso Wall Street
21 analisti · Apr 20264
Acquisto forte
10
Compra
6
Mantieni
1
Vendi
0
Vendita forte
66,7%
Rating Compra
Grafico dei Prezzi
Titoli simili
RYTM
Rhythm Pharmaceuticals Inc
$7.1B
SRRK
Scholar Rock Holding Corp
$4.5B
COGT
Cogent Biosciences Inc
$5.4B
CGON
CG Oncology Inc
$3.3B
MIRM
Mirum Pharmaceuticals Inc
$4.1B
ERAS
Erasca Inc
$1.1B
CAI
Caris Life Sciences Inc
$7.6B
CELC
Celcuity Inc
$4.6B
TGTX
TG Therapeutics Inc
P/E 10,6
$4.7B
APLS
Apellis Pharmaceuticals Inc
P/E 70,7
$3.2B
Utili
Tasso di battuta: 75,0%| Trimestre | EPS Stimato | EPS Effettivo | Sorpresa |
|---|---|---|---|
| Dic 2025 | $0,04 | $-1,67 | $-1,71 |
| Set 2025 | $-1,40 | $0,20 | +$1,60 |
| Giu 2025 | $-1,08 | $-0,83 | +$0,25 |
| Mar 2025 | $-0,22 | $10,04 | +$10,26 |
Trend fondamentali
| Metrica | 2025-06-30 | 2025-09-02 | 2025-10-02 | 2025-11-03 | 2025-12-03 | 2026-01-02 |
|---|---|---|---|---|---|---|
| ROE (TTM) | — | -351.9% | -351.9% | -351.9% | -351.9% | -351.9% |
| P/E (TTM) | 6.15 | 6.26 | 7.75 | 8.62 | 8.38 | 8.11 |
| Net Margin | -36.2% | 35.6% | 35.6% | 35.6% | 42.2% | 42.2% |
| Gross Margin | 93.6% | 97.1% | 97.1% | 97.1% | 96.8% | 96.8% |
| D/E Ratio | — | 84892.86 | 84892.86 | 84892.86 | 84892.86 | 84892.86 |
| Current Ratio | 3.62 | 3.62 | 3.62 | 3.62 | 2.32 | 2.32 |
Rapporti chiave
ROA (TTM)
31,2%
P/S (TTM)
3,43
P/B
1877,3
EPS (TTM)
$8,53
CF/Share
$-6,03
Crescita ricavi 3A
+14,4%
52W High
$87,50
52W Low
$35,95
$35,95
Intervallo 52 settimane
$87,50
Як PTCT виглядає на тлі конкурентів у Biotechnology?
Група порівняння: Micro-cap Biotechnology (All) · 528 компаній
Оцінка PTCT vs аналоги Biotechnology
P/E
8,1
▼
57%
sotto
peer
(18,8)
vs Peer
vs Settore
Sottovalutato
P/S
3,4
▼
73%
sotto
peer
(12,9)
vs Peer
vs Settore
Sottovalutato
P/B
1877,3
▲
76212%
sopra
peer
(2,5)
vs Peer
vs Settore
Sopravvalutato
Дивідендна дохідність
—
▼
0%
sotto
peer
(0,0%)
vs Peer
vs Settore
Rendimento basso
Прибутковість PTCT vs аналоги Biotechnology
ROE
-351,9%
▼
423%
sotto
peer
(-67,3%)
vs Peer
vs Settore
Debole
Net margin
42,3%
▲
115%
sopra
peer
(-286,8%)
vs Peer
vs Settore
Sotto media
Валова маржа
96,8%
▲
23%
sopra
peer
(78,6%)
vs Peer
vs Settore
Debole
ROA
31,2%
▲
167%
sopra
peer
(-46,7%)
vs Peer
vs Settore
Top livello
Фінансове здоровʼя PTCT vs аналоги Biotechnology
D/E ratio
84892,9
▼
0%
sotto
peer
(0,0)
vs Peer
vs Settore
Debito alto
Поточна ліквідність
2,3
▼
48%
sotto
peer
(4,4)
vs Peer
vs Settore
Liquidità bassa
Beta
0,5
▼
51%
sotto
peer
(1,0)
vs Peer
vs Settore
Più volatile
Радар фундаменталів PTCT
PTCT
Mediana peer
Industria
PTCT прибутковість vs борг
Розмір бульбашки = капіталізація · X = чиста маржа · Y = D/E ratio
PTCT vs аналоги: ключові метрики
Segnali Correlati
Ultima opinione AI
Grok
SKIP
Price action shows a steady decline from the November 2025 peak of around $80 to the current $64.67, with recent weeks trading sideways to lower between $66-70 without clear reversal signals or increasing volume on up days, making this not …
Mar 24, 2026Ultime notizie
Nessuna notizia correlata ancora